Document is current
Any future updates will be listed below
-
Authors
Wang, Yu Meng
Yan, Jing https://orcid.org/0000-0002-3402-5543
Williams, Sarah K. https://orcid.org/0000-0003-2770-6276
Fairless, Richard https://orcid.org/0000-0002-6817-9671
Bading, Hilmar https://orcid.org/0000-0003-0258-4348
-
Funding
Funding for this research was provided by:
Deutsche Forschungsgemeinschaft (BA 1007/7-1, FOR 2289)
HORIZON EUROPE European Research Council (Advanced Grant 233024)
Ruprecht-Karls-Universität Heidelberg
- License Information
-
More Information
Article History
Received: 28 May 2024
Accepted: 31 August 2024
First Online: 12 September 2024
Declarations
:
: All authors have read and approved the manuscript for publication.
: HB and JY are named inventors of the patent application for a novel class of neuroprotectants (PCT/EP2018/078577); HB is founder of FundaMental Pharma GmbH, Heidelberg, Germany, which licenses FP802. HB and JY are shareholders of FundaMental Pharma GmbH. Other authors report no competing interests.
